Risk of selecting de novo drug-resistance mutations during structured treatment interruptions in patients with chronic HIV infection.

Risk of selecting de novo drug-resistance mutations during structured treatment interruptions in patients with chronic HIV infection.

Item
http://www.wikidata.org/entity/Q38441406
Standing genetic variation and the evolution of drug resistance in HIVShort-cycle therapy in adolescents after continuous therapy with established viral suppression: the impact on viral load suppression.Global response to HIV: treatment as prevention, or treatment for treatment?Long-term outcome of patients after a single interruption of antiretroviral therapy: a cohort study.Association of circulating cytochrome c with clinical manifestations of antiretroviral-induced toxicityCD4+ T-cell-guided structured treatment interruptions of antiretroviral therapy in HIV disease: projecting beyond clinical trials.Suppression of viremia and evolution of human immunodeficiency virus type 1 drug resistance in a macaque model for antiretroviral therapy.Plasma drug concentrations and virologic evaluations after stopping treatment with nonnucleoside reverse-transcriptase inhibitors in HIV type 1-infected childrenVirological failure and development of new resistance mutations according to CD4 count at combination antiretroviral therapy initiation.Efficacy of a clinical decision-support system in an HIV practice: a randomized trial.Viral resuppression and detection of drug resistance following interruption of a suppressive non-nucleoside reverse transcriptase inhibitor-based regimenTowards an HIV-1 cure: measuring the latent reservoir.New challenges in therapeutic vaccines against HIV infection.Two-Months-off, Four-Months-on Antiretroviral Regimen Increases the Risk of Resistance, Compared with Continuous Therapy: A Randomized Trial Involving West African Adults
P2860

Risk of selecting de novo drug-resistance mutations during structured treatment interruptions in patients with chronic HIV infection.

Item
http://www.wikidata.org/entity/Q38441406
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Risk of selecting de novo drug ...... ts with chronic HIV infection.
@en
type
label
Risk of selecting de novo drug ...... ts with chronic HIV infection.
@en
prefLabel
Risk of selecting de novo drug ...... ts with chronic HIV infection.
@en
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P356
P1433
P1476
Risk of selecting de novo drug ...... ts with chronic HIV infection.
@en
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698